Sandoz Group AG (SWX: SDZ)

Market Cap	18.27B
Revenue (ttm)	9.09B
Net Income (ttm)	-7.19M
Shares Out	438.72M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	14.52
Dividend	0.45 (1.09%)
Ex-Dividend Date	n/a

Volume	1,051,458
Average Volume	967,013
Open	41.18
Previous Close	41.11
Day's Range	41.01 - 41.64
52-Week Range	25.33 - 41.64
Beta	n/a
RSI	73.71
Earnings Date	Mar 5, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,633
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SDZ

Financial Performance

In 2023, Sandoz Group AG's revenue was $9.98 billion, an increase of 7.23% compared to the previous year's $9.31 billion. Earnings were $77.00 million, a decrease of -90.92%.

Financial numbers in USD